02:06 PM EDT, 09/25/2024 (MT Newswires) -- Grifols ( GRFS ) is among three companies facing separate disciplinary proceedings initiated by Spain's National Securities Market Commission, the regulator said Wednesday.
The Spanish biopharmaceutical firm is facing possible sanctions over alleged inaccuracies and deficiencies in its financial reports, the regulator said.
Grifols ( GRFS ) did not immediately respond to MT Newswires' request for comment.
Shares of Grifols ( GRFS ) were down more than 2% in recent trading.
Price: 8.49, Change: -0.21, Percent Change: -2.41